AVITA MEDICAL INC. - Charts / Financials

4.12%

$1.39

Market Cap $41.08M

Healthcare Biotechnology

Avita Medical Limited is a regenerative medicine company with a technology platform to... Avita Medical Limited is a regenerative medicine company with a technology platform to address medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. The Company’s technology provides treatment solutions derived from the regenerative properties of a patient’s own skin. The medical devices work by preparing Spray-On Skin Cells, an autologous cellular suspension comprised of the patient’s skin cells necessary to regenerate natural healthy epidermis. Its product, the RECELL System for the treatment of acute thermal burn injuries in patients 18 years and older. The RECELL System is used to prepare Spray-On Skin Cells using a small amount of a patient’s own skin, providing a way to treat severe burns that significantly reduces the amount of donor skin required. The RECELL System is designed to be used at the point of care alone or in combination with split-thickness skin autografts depending on the depth of the burn injury. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

REFRESH

Last update - 16.21pm 17/07/2026 (20 minute delay)

Day
Open	$1.42		Day High	$1.42		Day Low	$1.34
Daily Volume	734213

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
0	$1.35	5000		0	$1.40	2535

Directors & Senior Management

Mr. Ben Atkins	Vice President of Investor Relations & Corporate Communications
Mr. Cary G. Vance	President, CEO & Executive Director
Mr. David O’Toole	Chief Financial Officer
Ms. Debbie Garner	Senior Vice President of Global Marketing & Strategy
Prof. Fiona Melanie Wood	Founder and Member of Clinical Advisory Board
Ms. Jan Stern Reed	Independent Chairman of the Board
Mr. Jeremy L. Curnock-Cook	Independent Non-Executive Director
Ms. Jessica Ekeberg	Director of Investor Relations
Mr. Joseph Fralin Woody	Independent Non-Executive Director
Dr. Katie Bush	Senior Vice President of Scientific & Medical Affairs
Dr. Michael Eric Tarnoff	Independent Non-Executive Director
Ms. Nicole Linda Kelsey	Chief Legal & Compliance Officer, Corporate Secretary and Interim SVP of Human Resources
Dr. Niraj Doshi	Senior Vice President of Global Operations
Mr. Robert E. McNamara	Independent Non-Executive Director
Ms. Robin VanDenburgh	Senior Vice President of U.S. Commercial Sales
Mr. Ron Lagerquist	Senior Vice President of Quality Assurance & Regulatory Affairs
Prof. Suzanne Crowe	Independent Non-Executive Director

Data source: ADVFN

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last $1.39		Change 0.055(4.12%)		Mkt cap ! $41.08M

Open	High	Low	Volume
$1.42	$1.42	$1.34	734.2K

Buyers (Bids)

Vol.	Price($)
5000	$1.35

Sellers (Offers)

Price($)	Vol.
$1.40	2535

Last trade - 16.21pm 17/07/2026 (20 minute delay)

AVH (ASX) Chart